BUHLMANN News - Buhlmann Diagnostics Corp - Newsletter - Tradeshow

BUHLMANN News

BUHLMANN Diagnostics Corp Recap from DDW 2024

Key Highlights BUHLMANN Diagnostics Corp is excited to share highlights from our participation at Digestive Disease Week (DDW) 2024,  held ...
Read More

CALEX Cap Updates- Extended Stability, Training Video & CALEX Cap 4.0

BÜHLMANN fCAL® turbo + CALEX® Cap (K191718 & K232057): FDA 510(k) cleared. For in vitro Diagnostic Use. BÜHLMANN fPELA® turbo is FDA ...
Read More

Visit BUHLMANN @ AMLI 2024 (LIVE)

AMLI 2024 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line ...
Read More

Visit BUHLMANN at ADLM 2024 (formerly AACC)

ADLM 2024 Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the ...
Read More
Connect with BUHLMANN at DDW 2024

Visit BUHLMANN at DDW 2024

Assay Offerings Assay Offerings: We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United ...
Read More
Visit BUHLMANN @ AACC 2023 (LIVE)

Visit BUHLMANN at AACC 2023 (Live)

AACC 2023 Assays Offerings Assays Offerings: BUHLMANN Diagnostic Corp (BDC), offers the broadest fecal calprotectin (fCAL) product range in the ...
Read More
Visit BUHLMANN @ AMLI 2023 (LIVE)

Visit BUHLMANN @ AMLI 2023 (LIVE)

AMLI 2023 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line ...
Read More

Visit BUHLMANN at DDW 2023

Assays Offerings Assays Offerings: We offer the broadest fecal calprotectin (fCAL) product range in the industry, available in the United ...
Read More